How to Manage Erectile Dysfunction After Prostate Cancer
Erectile dysfunction after prostate cancer is common but often manageable — and recovery odds rise sharply for younger men with nerve-sparing surgery.
How Doctors Choose Between Prostate Cancer Surgery and Radiation
Choosing between prostate cancer surgery and radiation? Survival is nearly the same for both—what differs is the side-effect trade-off.
PARP Inhibitors for BRCA-Linked Prostate Cancer Explained
PARP inhibitors work only against prostate cancers with BRCA or HRR mutations—a December 2025 FDA approval added a BRCA2 hormone-sensitive option.
A Clear Look at Immunotherapy for Prostate Cancer and Provenge
Immunotherapy for prostate cancer works differently than chemo: Provenge may extend survival even when scans don't shrink. Here's what that means for you.
How Pluvicto and Lutetium-177 Work in Prostate Cancer
Pluvicto, a lutetium-177 radioligand therapy, targets PSMA-positive metastatic prostate cancer — here's how it works and who qualifies.
When Chemotherapy for Prostate Cancer Is Needed
Hearing 'chemo' for prostate cancer is frightening, but it's used only when the cancer has spread—often with hormone therapy. See when it helps and how.
Understanding Your Hormone Therapy Plan for Prostate Cancer
Hormone therapy slows prostate cancer by lowering testosterone, but how long you stay on it ranges from months to years. Here's what to expect.
Know Your Radiation Therapy Options for Prostate Cancer
Radiation therapy for prostate cancer isn't one option but several, each with a different risk profile—from IMRT and SBRT to brachytherapy and Pluvicto.
A Realistic Look at Radical Prostatectomy Recovery
Radical prostatectomy recovery follows a clear arc—catheter out around 1–2 weeks, then continence and PSA milestones. Here's what to expect at each stage.
Know If Active Surveillance Fits Your Prostate Cancer
Active surveillance lets men with Gleason 6 prostate cancer monitor instead of treating now—see who qualifies and how it's tracked.